Literature DB >> 8841462

Preoperative radiotherapy and surgery for advanced thymoma with invasion to the great vessels.

E Akaogi1, K Ohara, K Mitsui, M Onizuka, S Ishikawa, T Mitsui, T Ogata.   

Abstract

From 1983 to 1994, 12 advanced thymomas with invasion to the great vessels were initially treated by irradiation (mean dose, 18.3 Gy) and subsequent surgical resection. In nine patients, complete resection was possible by concomitant resection of the surrounding tissues, mainly pericardium and/or brachiocephalic vein. Histologically, all tumors showed prominent fibrosis. Ten patients also received postoperative radiotherapy (mean dose, 42.3 Gy). Tumor-related deaths occurred in only two patients; one who did not receive postoperative irradiation 21 months and one who had viable cells at the surgical margin 10 months after operation. However, there were also 2 patients who died of respiratory failure due to operation and/or irradiation, one 45 days and the other 7 years after the treatment. Preoperative radiotherapy could facilitate complete resection of the advanced thymomas. The prognosis of the patients treated with preoperative radiotherapy seemed fair if followed by adequate resection and subsequent irradiation.

Entities:  

Mesh:

Year:  1996        PMID: 8841462     DOI: 10.1002/(SICI)1096-9098(199609)63:1<17::AID-JSO4>3.0.CO;2-T

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

Review 1.  Radiotherapy for thymic neoplasms.

Authors:  Clifton D Fuller; Emma H Ramahi; Noel Aherne; Tony Y Eng; Charles R Thomas
Journal:  J Thorac Oncol       Date:  2010-10       Impact factor: 15.609

2.  Excision after chemoradiotherapy of invasive thymoma extending into the right atrium: report of a case.

Authors:  Hideo Ichimura; Shingo Usui; Hiroo Okazaki; Taisuke Konishi; Motoo Osaka; Tomoaki Jikuya; Hidetsugu Nakayama; Kazunori Kikuchi; Yukinori Inadome; Masataka Onizuka
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

3.  Radiotherapy for invasive thymoma and thymic carcinoma. Clinicopathological review.

Authors:  R Mayer; C Beham-Schmid; R Groell; F M Smolle-Juettner; F Quehenberger; G F Stuecklschweiger; U Prettenhofer; H Stranzl; H Renner; A Hackl
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 4.033

Review 4.  Radiotherapy for thymic carcinoma: adjuvant, inductive, and definitive.

Authors:  Ritsuko Komaki; Daniel R Gomez
Journal:  Front Oncol       Date:  2014-01-10       Impact factor: 6.244

Review 5.  "Radiotherapy for thymic epithelial tumors: What is the optimal dose? A systematic review."

Authors:  A Angrisani; R Houben; F Marcuse; M Hochstenbag; J Maessen; D De Ruysscher; S Peeters
Journal:  Clin Transl Radiat Oncol       Date:  2022-03-19

6.  Induction Therapy Followed by Surgery for Unresectable Thymic Epithelial Tumours.

Authors:  Shuai Wang; Jiahao Jiang; Jian Gao; Gang Chen; Yue Fan; Bei Xu; Jihong Dong; Shisuo Du; Junzhen Liu; Jianyong Ding
Journal:  Front Oncol       Date:  2022-01-05       Impact factor: 6.244

7.  ASXL1 and DNMT3A mutation in a cytogenetically normal B3 thymoma.

Authors:  R Belani; G Oliveira; G A Erikson; S Ra; M S Schechter; J K Lee; W J Shipman; S M Haaser; A Torkamani
Journal:  Oncogenesis       Date:  2014-07-07       Impact factor: 7.485

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.